logo
Plus   Neg
Share
Email

West Pharmaceutical Services To Replace Helmerich & Payne In S&P 500

S&P Dow Jones Indices said that S&P MidCap 400 constituent West Pharmaceutical Services Inc. (WST) will replace Helmerich & Payne Inc. (HP) in the S&P 500.

Helmerich & Payne will replace J.C. Penney Company Inc. (JCP) in the S&P SmallCap 600, and Physicians Realty Trust (DOC) will replace West Pharmaceutical Services in the S&P MidCap 400.

S&P Dow Jones Indices stated that J.C. Penney filed to reorganize under Chapter 11 of the U.S. Bankruptcy Code and is no longer eligible for continued inclusion in the S&P SmallCap 600.

Helmerich & Payne has a market capitalization that is more representative of the small-cap market space.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
RELATED NEWS
Follow RTT